<DOC>
	<DOCNO>NCT01143727</DOCNO>
	<brief_summary>This study compare two standard method clean surface wound foot patient diabetes mellitus . The question ask whether inflammation wound affect ability one method work .</brief_summary>
	<brief_title>Enzymatic Versus ( v ) Autolytic Debridement Diabetic Foot Ulcers</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>The informed consent document must read , sign , date subject subject 's legally authorize representative conduct study procedure exams . In addition , informed consent document must sign date individual consent subject conduct screen visit . A photocopy sign informed consent document must provide subject , original sign document place subject 's chart . Of either sex , age 18 year old . A diagnosis Diabetes Mellitus , Type I II , require medication control blood glucose level . A qualifying ulcer , define follow : Ulcer grade 1 2 Wagner Classification Scale ( refer Section 9.4.1 ) Infection / inflammation grade 1 2 wound bed inflammation ( refer Section 9.4.2 ) Has treat respond treatment past 30 day Has apparent area ≥ 3.0 cm² Requires debridement wound bed Is sufficiently moist allow collection wound fluid use filter paper disc Adequate arterial blood flow evidence ankle brachial index ( ABI ) ≥ 0.7 ≤ 1.1 ; ABI great 1.1 , toe pressure &gt; 50 mmHg . Subject must willing use Darco shoe offload device insole , comparable device , indicate . Subject able follow instruction , particularly regard application test article dressing home . Able apply test article , caregiver available apply test article accord protocol . Contraindications know hypersensitivity test article component . Cellulitis extend &gt; 2 cm around target ulcer , lymphangitic streaking , spread beneath superficial fascia , deeptissue abscess , gangrene , infection muscle , tendon , joint bone . Target ulcer tunnel per probe visual assessment . Use systemic antibiotic drug list Section 9.1.6 protocol within 10 day SCR visit . Concomitant illness condition , opinion Principal Investigator , place subject risk study . The Medical Monitor may declare subject ineligible valid procedural medical reason .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>